Overview
Mytomorrows, a Dutch healthtech company that connects patients with pre-approval treatments, has secured €25 million in funding led by Avego to enhance its AI-powered platform. The investment aims to improve access to emerging therapies for over 300 million patients worldwide, addressing critical gaps in healthcare.
Products
Loading...
Recent Deals
Investors: Avego
Mytomorrows, a Dutch healthtech company that connects patients with pre-approval treatments, has secured €25 million in funding led by Avego to enhance its AI-powered platform. The investment aims to improve access to emerging therapies for over 300 million patients worldwide, addressing critical gaps in healthcare.